I'd argue it's quite hard to sit on, biotech has been a leading theme for a while now and there are a number of biotech stocks today that are green/have put in strong MTD performances all whilst $EYE has made zero movement in 7 months..
The opportunity cost of owning a stock with no material SP improvement is quite high at the moment.
The directors aren't doing enough to promote this story, made more evident but the number of spelling errors in their recent LinkedIn post that was shared here earlier today.
Nova Eye Medical (EYE) Chart Thread, page-260
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $54.97M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.5¢ | $6.225K | 26.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27790 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 2255 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |